BioSpace News Archive

Business

Myriad Collaborates With Department of Veterans Affairs in Large Trial Evaluating the GeneSight Test to Improve Mental Health Outcomes for Veterans

The 2,000 patient study will leverage GeneSight test to guide therapy selection.

November 10, 2017

·

9 min read

IRX Therapeutics Announces Presentation of IRX-2 Phase Ib Biomarker Data in Early Stage Breast Cancer

The results will be presented on Saturday, November 11 at the Society for Immunotherapy of Cancer’s (SITC) 31st Annual Meeting.

November 10, 2017

·

4 min read

Business

Kamada Announces Nomination of Three New Members to its Board of Directors

The new nominees will stand for election at Kamada’s 2017 Annual General Meeting of Shareholders on November 30, 2017 (the “AGM”).

November 10, 2017

·

5 min read

FDA

Teligent Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%

This is Teligent’s seventh approval for 2017.

November 10, 2017

·

2 min read

Pharm Country

Adaptimmune Presents Study Designs for Ongoing MAGE-A4 and NY-ESO SPEAR T-cell Clinical Trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

The posters summarized study designs for ongoing clinical trials with MAGE-A4 and NY-ESO SPEAR T-cells.

November 10, 2017

·

5 min read

Business

MediciNova Announces Collaboration With the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (ibudilast) in Methamphetamine Use Disorder

The proposed clinical trial will evaluate MN-166 (ibudilast) as a potential treatment for individuals diagnosed with MA use disorder with or without post-traumatic stress disorder.

November 10, 2017

·

8 min read

BioCapital

Sucampo to Host 2017 R&D Day on November 16 in New York

Sucampo will highlight its two Phase 3 rare and orphan drug programs in Niemann-Pick Disease Type C1 (NPC-1) and Familial Adenomatous Polyposis (FAP).

November 10, 2017

·

4 min read

Ablynx: Publication in Accordance With Article 14 of The Belgian Law of 2 May 2007 Regarding The Publication of Major Shareholdings (The “Transparency Law”) - Nov. 10, 2017

The company received a notification of shareholdings from Millennium Group Management LLC on 7 November 2017.

November 10, 2017

·

4 min read

Drug Development

Deciphera Pharmaceuticals Reports Data Analysis From the Ongoing Phase I Clinical Trial of DCC-2618 at the Annual Meeting of The Connective Tissue Oncology Society

The presentation reviews data from the same trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in September 2017.

November 10, 2017

·

8 min read

BioMidwest

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

Trading of the common shares on the NYSE American will not commence until after Zomedica’s Registration Statement on Form S-1 is declared effective by the U.S. Securities and Exchange Commission (the “SEC”).

November 10, 2017

·

1 min read